DexCom (DXCM) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $82.97 --0%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.
GUIDANCE:
DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Twin Disc (TWIN) Tops Q1 EPS by 13c
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
